159 related articles for article (PubMed ID: 8800093)
1. The glial and mesenchymal elements of gliosarcomas share similar genetic alterations.
Boerman RH; Anderl K; Herath J; Borell T; Johnson N; Schaeffer-Klein J; Kirchhof A; Raap AK; Scheithauer BW; Jenkins RB
J Neuropathol Exp Neurol; 1996 Sep; 55(9):973-81. PubMed ID: 8800093
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.
Actor B; Cobbers JM; Büschges R; Wolter M; Knobbe CB; Lichter P; Reifenberger G; Weber RG
Genes Chromosomes Cancer; 2002 Aug; 34(4):416-27. PubMed ID: 12112531
[TBL] [Abstract][Full Text] [Related]
3. Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells.
Biernat W; Aguzzi A; Sure U; Grant JW; Kleihues P; Hegi ME
J Neuropathol Exp Neurol; 1995 Sep; 54(5):651-6. PubMed ID: 7666053
[TBL] [Abstract][Full Text] [Related]
4. Amplification of the STOML3, FREM2, and LHFP genes is associated with mesenchymal differentiation in gliosarcoma.
Nagaishi M; Kim YH; Mittelbronn M; Giangaspero F; Paulus W; Brokinkel B; Vital A; Tanaka Y; Nakazato Y; Legras-Lachuer C; Lachuer J; Ohgaki H
Am J Pathol; 2012 May; 180(5):1816-23. PubMed ID: 22538188
[TBL] [Abstract][Full Text] [Related]
5. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
[TBL] [Abstract][Full Text] [Related]
6. Genetic profile of gliosarcomas.
Reis RM; Könü-Lebleblicioglu D; Lopes JM; Kleihues P; Ohgaki H
Am J Pathol; 2000 Feb; 156(2):425-32. PubMed ID: 10666371
[TBL] [Abstract][Full Text] [Related]
7. Genetic and pathologic evolution of early secondary gliosarcoma.
Codispoti KE; Mosier S; Ramsey R; Lin MT; Rodriguez FJ
Brain Tumor Pathol; 2014 Jan; 31(1):40-6. PubMed ID: 23324827
[TBL] [Abstract][Full Text] [Related]
8. Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma.
Oh JE; Ohta T; Nonoguchi N; Satomi K; Capper D; Pierscianek D; Sure U; Vital A; Paulus W; Mittelbronn M; Antonelli M; Kleihues P; Giangaspero F; Ohgaki H
Brain Pathol; 2016 Jul; 26(4):517-22. PubMed ID: 26443480
[TBL] [Abstract][Full Text] [Related]
9. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study.
Rodriguez FJ; Scheithauer BW; Giannini C; Bryant SC; Jenkins RB
Cancer; 2008 Nov; 113(10):2779-89. PubMed ID: 18816605
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional factors for epithelial-mesenchymal transition are associated with mesenchymal differentiation in gliosarcoma.
Nagaishi M; Paulus W; Brokinkel B; Vital A; Tanaka Y; Nakazato Y; Giangaspero F; Ohgaki H
Brain Pathol; 2012 Sep; 22(5):670-6. PubMed ID: 22288519
[TBL] [Abstract][Full Text] [Related]
11. Interphase cytogenetics of glioblastoma and gliosarcoma.
Paulus W; Bayas A; Ott G; Roggendorf W
Acta Neuropathol; 1994; 88(5):420-5. PubMed ID: 7847070
[TBL] [Abstract][Full Text] [Related]
12. Gliosarcomas with the
Wang L; Sun J; Li Z; Chen L; Fu Y; Zhao L; Liu L; Wei Y; Teng L; Lu D
J Clin Pathol; 2017 Dec; 70(12):1079-1083. PubMed ID: 28775171
[TBL] [Abstract][Full Text] [Related]
13. Molecular cytogenetic analysis of a gliosarcoma with osseous metaplasia.
Dahlback HS; Gorunova L; Micci F; Scheie D; Brandal P; Meling TR; Heim S
Cytogenet Genome Res; 2011; 134(2):88-95. PubMed ID: 21555877
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
[TBL] [Abstract][Full Text] [Related]
15. Gliosarcoma: an immunohistochemical, ultrastructural and fluorescence in situ hybridization study.
Horiguchi H; Hirose T; Kannuki S; Nagahiro S; Sano T
Pathol Int; 1998 Aug; 48(8):595-602. PubMed ID: 9736406
[TBL] [Abstract][Full Text] [Related]
16. Gliosarcoma. A study of 13 tumors, including p53 and CD34 immunohistochemistry.
Sreenan JJ; Prayson RA
Arch Pathol Lab Med; 1997 Feb; 121(2):129-33. PubMed ID: 9126039
[TBL] [Abstract][Full Text] [Related]
17. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.
Cachia D; Kamiya-Matsuoka C; Mandel JJ; Olar A; Cykowski MD; Armstrong TS; Fuller GN; Gilbert MR; De Groot JF
J Neurooncol; 2015 Nov; 125(2):401-10. PubMed ID: 26354773
[TBL] [Abstract][Full Text] [Related]
18. Ependymal tumors with sarcomatous change ("ependymosarcoma"): a clinicopathologic and molecular cytogenetic study.
Rodriguez FJ; Scheithauer BW; Perry A; Oliveira AM; Jenkins RB; Oviedo A; Mork SJ; Palmer CA; Burger PC
Am J Surg Pathol; 2008 May; 32(5):699-709. PubMed ID: 18347506
[TBL] [Abstract][Full Text] [Related]
19. Gliosarcoma arising from an oligodendroglioma (oligosarcoma).
Hiniker A; Hagenkord JM; Powers MP; Aghi MK; Prados MD; Perry A
Clin Neuropathol; 2013; 32(3):165-70. PubMed ID: 23254140
[TBL] [Abstract][Full Text] [Related]
20. Gliosarcoma with osseous tissue: an occasional metaplastic component.
Tyagi I; Majumdar K; Mehta S; Batra VV
Brain Tumor Pathol; 2013 Jan; 30(1):40-4. PubMed ID: 22476731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
